Condition
Congenital Mitral Insufficiency
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown3
Clinical Trials (3)
Showing 3 of 3 trials
NCT06039592UnknownPrimary
Study of Innovative Drug Strategies in Improving Left Ventricular Function After Mitral Repair
NCT06037434UnknownPrimary
Study of Innovative Drug Treatment Therapy for Pediatric Mitral Regurgitation
NCT06037447UnknownPrimary
Study of Innovative Strategies for Mitral Valve Repair
Showing all 3 trials